vincristine lyophilezed
aventis pharma - injection - 1 mg
clexane 20
aventis pharma - enoxaparin sodium - injectable; injection - 20mg/0.2ml
clexane 60
aventis pharma - enoxaparin sodium - injectable; injection - 60mg/0.6ml
clexane 80
aventis pharma - enoxaparin sodium - injectable; injection - 80mg
taxotere 20
aventis pharma - docetaxel - injectable; iv (infusion) - 20mg/0.5ml
taxotere 80mg vial +solvent solution
aventis pharma limited - docetaxel - solution - 80 mg
apidra
pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: cresol hydrochloric acid polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.
apidra solostar
pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: hydrochloric acid metacresol polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.
arava
sanofi-aventis new zealand limited - leflunomide 100mg - film coated tablet - 100 mg - active: leflunomide 100mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease
arava
pharmacy retailing (nz) ltd t/a healthcare logistics - leflunomide 10mg - film coated tablet - 10 mg - active: leflunomide 10mg excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch povidone purified talc titanium dioxide - arava is indicated for the treatment of: · rheumatoid arthritis, to improve signs and symptoms to retard joint destruction and to improve functional ability and quality of life. leflunomide may be used in patients who have failed to respond to other treatments or as a first line of treatment in patients who have a contraindication to other treatments. · active psoriatic arthritis. arava is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease